PYC
PYC.AXPYC Therapeutics Limited Price (PYC.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
3,935,910,623
(21.1491)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
PYC Therapeutics LimitedCurrency: AUD
| YEAR | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Revenue |
52.56k
+0% |
0.00
+0% |
275.39k
+0% |
90.75k
-67% |
1.27M
+1,305% |
596.26k
-53% |
2.36M
+296% |
1.92M
-19% |
711.89k
-63% |
739.39k
+4% |
829.12k
+12% |
1.08k
-100% |
2.76M
+256,660% |
48.46k
-98% |
0.00
+0% |
2.40M
+0% |
3.07M
+28% |
16.04M
+422% |
15.81M
-1% |
22.06M
+40% |
|
| Cost of Revenue | |||||||||||||||||||||
| Cost of Revenue | 0.00 | 137.23k | 272.50k | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.27M | 3.62M | 3.58M | 122.12k | 4.67M | 81.30k | 130.56k | 547.11k | 622.36k | 839.51k | 882.05k | 0.00 | |
| Gross Profit | |||||||||||||||||||||
| Gross Profit |
52.56k
+0% |
-137,232.00
-361% |
2.89k
-102% |
90.75k
+3,041% |
1.27M
+1,305% |
596.26k
-53% |
2.36M
+296% |
1.92M
-19% |
-2,554,845.00
-233% |
-2,880,062.00
+13% |
-2,749,331.00
-5% |
-121,039.00
-96% |
-1,909,271.00
+1,477% |
-32,838.00
-98% |
-130,556.00
+298% |
1.85M
-1,516% |
2.45M
+33% |
15.20M
+520% |
14.92M
-2% |
22.06M
+48% |
|
| Gross Profit Ratio | (1.00%) | (0.00%) | (0.01%) | (1.00%) | (1.00%) | (1.00%) | (1.00%) | (1.00%) | (-3.59%) | (-3.90%) | (-3.32%) | (-112.49%) | (-0.69%) | (-0.68%) | (0.00%) | (0.77%) | (0.80%) | (0.95%) | (0.94%) | (1.00%) | |
| Operating Expenses | |||||||||||||||||||||
| Research and Development | 407.78k | 1.38M | 0.00 | 2.28M | 0.00 | 0.00 | 0.00 | 0.00 | 4.04M | 4.18M | 4.12M | 4.86M | 4.67M | 6.96M | 4.51M | 5.88M | 14.00M | 24.03M | 35.15M | 56.41M | |
| General and Administrative | 1.26M | 1.59M | 1.91M | 2.02M | 1.35M | 1.36M | 1.53M | 1.39M | 1.55M | 433.96k | 541.46k | 903.76k | 1.04M | 1.16M | 1.83M | 3.82M | 7.83M | 6.30M | 4.09M | 4.51M | |
| Selling, General & Admin... | 1.26M | 1.59M | 1.91M | 2.02M | 1.35M | 1.36M | 1.53M | 1.39M | 1.55M | 1.80M | 1.86M | 973.56k | 1.85M | 2.72M | 2.46M | 3.28M | 7.21M | 5.34M | 3.14M | 4.51M | |
| Selling & Marketing Exp... | 0.00 | 19.93k | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.37M | 1.31M | 1.11M | 814.49k | 1.42M | 1.82M | -541,472.00 | -622,362.00 | -960,358.00 | -956,086.00 | 0.00 | |
| Depreciation and Amortiz... | 42.30k | 18.14k | 26.28k | 49.48k | 114.03k | 66.94k | 154.54k | 196.30k | 274.17k | 214.26k | 212.24k | 122.12k | 55.26k | 81.30k | 130.56k | 547.11k | 622.36k | 839.51k | 882.05k | 1.07M | |
| Other Expenses | 127.42k | 33.77k | 605.47k | 783.62k | 3.63M | 3.90M | 4.55M | 4.60M | 711.89k | 47.24k | 65.74k | 1.08k | 2.76M | 48.46k | 250.00 | 62.50k | 3.13M | 15.92M | 15.75M | 0.00 | |
| Total Operating Expenses | 1.79M | 3.94M | 4.70M | 5.66M | 4.98M | 5.26M | 6.08M | 5.98M | 6.10M | 2.26M | 2.28M | 5.83M | 2.34M | 9.69M | 6.97M | 9.15M | 21.21M | 29.37M | 38.28M | 60.92M | |
| Cost and Exponses | 1.79M | 4.08M | 4.97M | 5.66M | 4.98M | 5.26M | 6.08M | 5.98M | 6.10M | 5.88M | 5.86M | 5.95M | 7.01M | 9.77M | 7.10M | 9.70M | 21.83M | 30.21M | 39.16M | 60.92M | |
| Operating Income | |||||||||||||||||||||
| Operating Income |
-1,740,919.00
+0% |
-4,076,800.00
+134% |
-4,695,773.00
+15% |
-5,573,815.00
+19% |
-3,702,574.00
-34% |
-4,664,483.00
+26% |
-3,717,689.00
-20% |
-4,066,070.00
+9% |
-6,104,530.00
+50% |
-5,136,138.00
-16% |
-5,033,278.00
-2% |
-5,950,980.00
+18% |
-4,251,606.00
-29% |
-9,768,150.00
+130% |
-7,102,100.00
-27% |
-9,701,850.00
+37% |
-21,832,850.00
+125% |
-30,207,770.00
+38% |
-39,163,120.00
+30% |
-38,857,226.00
-1% |
|
| Operating Income Ratio | (-33.13%) | (0.00%) | (-17.05%) | (-61.42%) | (-2.90%) | (-7.82%) | (-1.58%) | (-2.12%) | (-8.58%) | (-6.95%) | (-6.07%) | (-5,530.65%) | (-1.54%) | (-201.57%) | (0.00%) | (-4.05%) | (-7.10%) | (-1.88%) | (-2.48%) | (-1.76%) | |
| Other Income and Exp... | |||||||||||||||||||||
| Interest Income | 111.29k | 231.82k | 201.63k | 306.26k | 104.42k | 91.66k | 112.52k | 161.55k | 73.78k | 86.48k | 75.32k | 178.68k | 75.86k | 114.88k | 117.96k | 207.03k | 108.50k | 24.43k | 81.85k | 795.98k | |
| Interest Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.92k | 38.82k | 32.60k | 27.29k | 49.21k | |
| Total Other Income/Exp... | 153.60k | 254.25k | 807.10k | 1.09M | -788,346.00 | 91.66k | 112.52k | 161.55k | 73.78k | 133.72k | -74,894.00 | -94,941.00 | 78.34k | 6.64M | 118.21k | 226.61k | -2,942,539.00 | -8,170.00 | -15,731,828.00 | -16,812,547.00 | |
| EBITDA | |||||||||||||||||||||
| EBITDA | -1,698,617.00 | -3,592,387.00 | -4,669,495.00 | -5,524,338.00 | -3,588,544.00 | -4,597,542.00 | -3,563,153.00 | -3,869,772.00 | -5,044,693.00 | -4,921,882.00 | -4,821,043.00 | -6,102,483.00 | -4,196,351.00 | -9,638,389.00 | -6,971,545.00 | -8,885,209.00 | -21,039,838.00 | -29,394,686.00 | -38,253,399.00 | -38,117,552.00 | |
| EBITDA ratio | (-32.32%) | (0.00%) | (-16.96%) | (-60.87%) | (-2.11%) | (-7.71%) | (-1.51%) | (-2.02%) | (-8.19%) | (-6.66%) | (-5.81%) | (-5,417.16%) | (-1.52%) | (-199.89%) | (0.00%) | (-3.82%) | (-6.90%) | (-1.83%) | (-2.42%) | (-1.73%) | |
| Income Before Tax | |||||||||||||||||||||
| Income Before Tax | -1,587,323.00 | -4,277,488.00 | -3,888,673.00 | -4,483,938.00 | -4,490,920.00 | -4,572,825.00 | -3,605,169.00 | -3,904,524.00 | -5,318,862.00 | -5,049,660.00 | -4,957,959.00 | -6,045,920.00 | -4,175,741.00 | -9,604,811.00 | -6,983,888.00 | -9,475,245.00 | -21,701,019.00 | -30,266,789.00 | -39,162,736.00 | -55,669,773.00 | |
| Income Before Tax Ratio | (-30.20%) | (0.00%) | (-14.12%) | (-49.41%) | (-3.52%) | (-7.67%) | (-1.53%) | (-2.04%) | (-7.47%) | (-6.83%) | (-5.98%) | (-5,618.88%) | (-1.51%) | (-198.20%) | (0.00%) | (-3.96%) | (-7.06%) | (-1.89%) | (-2.48%) | (-2.52%) | |
| Income Tax Expense | |||||||||||||||||||||
| Income Tax Expense | -1,587,323.00 | -286,013.00 | -201,628.00 | -306,256.00 | 788.35k | 0.00 | 0.00 | 0.00 | -1,879,238.00 | 1.79M | 1.97M | -2,067,248.00 | 2.22M | -2,170,814.00 | -2,904,120.00 | -2,395,706.00 | -3,071,018.00 | -15,972,821.00 | -15,806,256.00 | -17,559,314.00 | |
| Net Income | |||||||||||||||||||||
| Net Income | -1,587,323.00
+0% |
-3,991,475.00
+151% |
-3,888,673.00
-3% |
-4,483,938.00
+15% |
-4,490,920.00
+0% |
-4,572,825.00
+2% |
-3,605,169.00
-21% |
-3,904,524.00
+8% |
-3,439,624.00
-12% |
-3,257,695.00
-5% |
-2,991,479.00
-8% |
-3,978,672.00
+33% |
-1,950,837.00
-51% |
-7,433,997.00
+281% |
-4,079,767.00
-45% |
-6,822,215.00
+67% |
-17,767,586.00
+160% |
-13,863,159.00
-22% |
-22,788,985.00
+64% |
-37,725,411.00
+66% |
|
| Net Income Ratio | (-30.20%) | (0.00%) | (-14.12%) | (-49.41%) | (-3.52%) | (-7.67%) | (-1.53%) | (-2.04%) | (-4.83%) | (-4.41%) | (-3.61%) | (-3,697.65%) | (-0.71%) | (-153.40%) | (0.00%) | (-2.85%) | (-5.78%) | (-0.86%) | (-1.44%) | (-1.71%) | |
| Earning Per Share | |||||||||||||||||||||
| Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 | |
| Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 | |
| Share Outstanding | |||||||||||||||||||||
| Basic Share Outstanding | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 1.96B | 2.80B | 2.22B | 2.80B | 2.80B | 3.13B | 3.22B | 3.25B | 3.93B | |
| Diluted Share Outstanding | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 2.80B | 1.96B | 2.80B | 2.22B | 2.80B | 2.80B | 3.13B | 3.22B | 3.25B | 3.94B | |